翻訳と辞書 |
Figitumumab
Figitumumab (previously CP-751871) is a monoclonal antibody〔(Statement On A Nonproprietary Name Adopted By The Usan Council - Figitumumab ), ''American Medical Association''.〕 targeting the insulin-like growth factor-1 receptor that was investigated for the treatment of various types of cancer, for example adrenocortical carcinoma and non-small cell lung cancer (NSCLC). This drug was being developed by Pfizer, but they ceased development of the drug in January 2011 and has stopped its manufacture. ==Anti-cancer mechanism== See Insulin-like growth factor 1 receptor role in cancer.
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Figitumumab」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|